Estimated Community Seroprevalence of SARS-CoV-2 Antibodies - Two Georgia Counties, April 28-May 3, 2020.
Adolescent
Adult
Aged
Antibodies, Viral
/ blood
Betacoronavirus
/ immunology
COVID-19 Testing
Child
Child, Preschool
Clinical Laboratory Techniques
Coronavirus Infections
/ diagnosis
Female
Georgia
/ epidemiology
Humans
Infant
Infant, Newborn
Male
Middle Aged
Public Health Surveillance
/ methods
Residence Characteristics
/ statistics & numerical data
SARS-CoV-2
Young Adult
Journal
MMWR. Morbidity and mortality weekly report
ISSN: 1545-861X
Titre abrégé: MMWR Morb Mortal Wkly Rep
Pays: United States
ID NLM: 7802429
Informations de publication
Date de publication:
24 Jul 2020
24 Jul 2020
Historique:
entrez:
24
7
2020
pubmed:
24
7
2020
medline:
25
7
2020
Statut:
epublish
Résumé
Transmission of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is ongoing in many communities throughout the United States. Although case-based and syndromic surveillance are critical for monitoring the pandemic, these systems rely on persons obtaining testing or reporting a COVID-19-like illness. Using serologic tests to detect the presence of SARS-CoV-2 antibodies is an adjunctive strategy that estimates the prevalence of past infection in a population. During April 28-May 3, 2020, coinciding with the end of a statewide shelter-in-place order, CDC and the Georgia Department of Public Health conducted a serologic survey in DeKalb and Fulton counties in metropolitan Atlanta to estimate SARS-CoV-2 seroprevalence in the population. A two-stage cluster sampling design was used to randomly select 30 census blocks in each county, with a target of seven participating households per census block. Weighted estimates were calculated to account for the probability of selection and adjusted for age group, sex, and race/ethnicity. A total of 394 households and 696 persons participated and had a serology result; 19 (2.7%) of 696 persons had SARS-CoV-2 antibodies detected. The estimated weighted seroprevalence across these two metropolitan Atlanta counties was 2.5% (95% confidence interval [CI] = 1.4-4.5). Non-Hispanic black participants more commonly had SARS-CoV-2 antibodies than did participants of other racial/ethnic groups (p<0.01). Among persons with SARS-CoV-2 antibodies, 13 (weighted % = 49.9; 95% CI = 24.4-75.5) reported a COVID-19-compatible illness,* six (weighted % = 28.2; 95% CI = 11.9-53.3) sought medical care for a COVID-19-compatible illness, and five (weighted % = 15.7; 95% CI = 5.1-39.4) had been tested for SARS-CoV-2 infection, demonstrating that many of these infections would not have been identified through case-based or syndromic surveillance. The relatively low seroprevalence estimate in this report indicates that most persons in the catchment area had not been infected with SARS-CoV-2 at the time of the survey. Continued preventive measures, including social distancing, consistent and correct use of face coverings, and hand hygiene, remain critical in controlling community spread of SARS-CoV-2.
Identifiants
pubmed: 32701941
doi: 10.15585/mmwr.mm6929e2
pmc: PMC7377817
doi:
Substances chimiques
Antibodies, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
965-970Investigateurs
Nicole Brown
(N)
Karen T Chang
(KT)
Nicholas P Deputy
(NP)
Rodel Desamu-Thorpe
(R)
Chase Gorishek
(C)
Arianna Hanchey
(A)
Michael Melgar
(M)
Benjamin P Monroe
(BP)
Carrie F Nielsen
(CF)
Gerald J Pellegrini
(GJ)
Mays Shamout
(M)
Laura I Tison
(LI)
Sara Vagi
(S)
Rachael Zacks
(R)
Déclaration de conflit d'intérêts
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
Références
Biometrics. 2015 Sep;71(3):832-40
pubmed: 25762089
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32381641
Ann Epidemiol. 2020 Jun 17;:
pubmed: 32648546
JAMA. 2020 May 18;:
pubmed: 32421144
MMWR Morb Mortal Wkly Rep. 2020 Jun 19;69(24):759-765
pubmed: 32555134